Transcriptional expression of Bcl-2 as predictive of response to neoadjuvant chemotherapy with trastuzumab in HER2-positive ER-positive breast cancer patients.
Maki Tanioka
No relevant relationships to disclose
Kazuko Sakai
No relevant relationships to disclose
Tamotsu Sudo
No relevant relationships to disclose
Toshiko Sakuma
No relevant relationships to disclose
Kouichi Hirokaga
No relevant relationships to disclose
Shintaro Takao
No relevant relationships to disclose
Hironobu Minami
Consultant or Advisory Role - Chugai Pharma
Honoraria - Chugai Pharma
Research Funding - Chugai Pharma
Shunichi Negoro
No relevant relationships to disclose
Kazuhiko Nakagawa
No relevant relationships to disclose
Kazuto Nishio
No relevant relationships to disclose